2023-08-012024-07-312024-07-31false10079282DR JOHNSON DEVELOPMENTS LTD2025-01-3041202falseiso4217:GBPxbrli:pure100792822023-08-01100792822024-07-31100792822023-08-012024-07-31100792822022-08-01100792822023-07-31100792822022-08-012023-07-3110079282bus:SmallEntities2023-08-012024-07-3110079282bus:AuditExempt-NoAccountantsReport2023-08-012024-07-3110079282bus:FullAccounts2023-08-012024-07-3110079282bus:PrivateLimitedCompanyLtd2023-08-012024-07-3110079282core:WithinOneYear2024-07-3110079282core:AfterOneYear2024-07-3110079282core:WithinOneYear2023-07-3110079282core:AfterOneYear2023-07-3110079282core:ShareCapital2024-07-3110079282core:SharePremium2024-07-3110079282core:RevaluationReserve2024-07-3110079282core:OtherReservesSubtotal2024-07-3110079282core:RetainedEarningsAccumulatedLosses2024-07-3110079282core:ShareCapital2023-07-3110079282core:SharePremium2023-07-3110079282core:RevaluationReserve2023-07-3110079282core:OtherReservesSubtotal2023-07-3110079282core:RetainedEarningsAccumulatedLosses2023-07-3110079282core:LandBuildings2024-07-3110079282core:PlantMachinery2024-07-3110079282core:Vehicles2024-07-3110079282core:FurnitureFittings2024-07-3110079282core:OfficeEquipment2024-07-3110079282core:NetGoodwill2024-07-3110079282core:IntangibleAssetsOtherThanGoodwill2024-07-3110079282core:ListedExchangeTraded2024-07-3110079282core:UnlistedNon-exchangeTraded2024-07-3110079282core:LandBuildings2023-07-3110079282core:PlantMachinery2023-07-3110079282core:Vehicles2023-07-3110079282core:FurnitureFittings2023-07-3110079282core:OfficeEquipment2023-07-3110079282core:NetGoodwill2023-07-3110079282core:IntangibleAssetsOtherThanGoodwill2023-07-3110079282core:ListedExchangeTraded2023-07-3110079282core:UnlistedNon-exchangeTraded2023-07-3110079282core:LandBuildings2023-08-012024-07-3110079282core:PlantMachinery2023-08-012024-07-3110079282core:Vehicles2023-08-012024-07-3110079282core:FurnitureFittings2023-08-012024-07-3110079282core:OfficeEquipment2023-08-012024-07-3110079282core:NetGoodwill2023-08-012024-07-3110079282core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3110079282core:ListedExchangeTraded2023-08-012024-07-3110079282core:UnlistedNon-exchangeTraded2023-08-012024-07-3110079282core:MoreThanFiveYears2023-08-012024-07-3110079282core:Non-currentFinancialInstruments2024-07-3110079282core:Non-currentFinancialInstruments2023-07-3110079282dpl:CostSales2023-08-012024-07-3110079282dpl:DistributionCosts2023-08-012024-07-3110079282core:LandBuildings2023-08-012024-07-3110079282core:PlantMachinery2023-08-012024-07-3110079282core:Vehicles2023-08-012024-07-3110079282core:FurnitureFittings2023-08-012024-07-3110079282core:OfficeEquipment2023-08-012024-07-3110079282dpl:AdministrativeExpenses2023-08-012024-07-3110079282core:NetGoodwill2023-08-012024-07-3110079282core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3110079282dpl:GroupUndertakings2023-08-012024-07-3110079282dpl:ParticipatingInterests2023-08-012024-07-3110079282dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3110079282core:ListedExchangeTraded2023-08-012024-07-3110079282dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3110079282core:UnlistedNon-exchangeTraded2023-08-012024-07-3110079282dpl:CostSales2022-08-012023-07-3110079282dpl:DistributionCosts2022-08-012023-07-3110079282core:LandBuildings2022-08-012023-07-3110079282core:PlantMachinery2022-08-012023-07-3110079282core:Vehicles2022-08-012023-07-3110079282core:FurnitureFittings2022-08-012023-07-3110079282core:OfficeEquipment2022-08-012023-07-3110079282dpl:AdministrativeExpenses2022-08-012023-07-3110079282core:NetGoodwill2022-08-012023-07-3110079282core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3110079282dpl:GroupUndertakings2022-08-012023-07-3110079282dpl:ParticipatingInterests2022-08-012023-07-3110079282dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-012023-07-3110079282core:ListedExchangeTraded2022-08-012023-07-3110079282dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-012023-07-3110079282core:UnlistedNon-exchangeTraded2022-08-012023-07-3110079282core:NetGoodwill2024-07-3110079282core:IntangibleAssetsOtherThanGoodwill2024-07-3110079282core:LandBuildings2024-07-3110079282core:PlantMachinery2024-07-3110079282core:Vehicles2024-07-3110079282core:FurnitureFittings2024-07-3110079282core:OfficeEquipment2024-07-3110079282core:AfterOneYear2024-07-3110079282core:WithinOneYear2024-07-3110079282core:ListedExchangeTraded2024-07-3110079282core:UnlistedNon-exchangeTraded2024-07-3110079282core:ShareCapital2024-07-3110079282core:SharePremium2024-07-3110079282core:RevaluationReserve2024-07-3110079282core:OtherReservesSubtotal2024-07-3110079282core:RetainedEarningsAccumulatedLosses2024-07-3110079282core:NetGoodwill2023-07-3110079282core:IntangibleAssetsOtherThanGoodwill2023-07-3110079282core:LandBuildings2023-07-3110079282core:PlantMachinery2023-07-3110079282core:Vehicles2023-07-3110079282core:FurnitureFittings2023-07-3110079282core:OfficeEquipment2023-07-3110079282core:AfterOneYear2023-07-3110079282core:WithinOneYear2023-07-3110079282core:ListedExchangeTraded2023-07-3110079282core:UnlistedNon-exchangeTraded2023-07-3110079282core:ShareCapital2023-07-3110079282core:SharePremium2023-07-3110079282core:RevaluationReserve2023-07-3110079282core:OtherReservesSubtotal2023-07-3110079282core:RetainedEarningsAccumulatedLosses2023-07-3110079282core:NetGoodwill2022-08-0110079282core:IntangibleAssetsOtherThanGoodwill2022-08-0110079282core:LandBuildings2022-08-0110079282core:PlantMachinery2022-08-0110079282core:Vehicles2022-08-0110079282core:FurnitureFittings2022-08-0110079282core:OfficeEquipment2022-08-0110079282core:AfterOneYear2022-08-0110079282core:WithinOneYear2022-08-0110079282core:ListedExchangeTraded2022-08-0110079282core:UnlistedNon-exchangeTraded2022-08-0110079282core:ShareCapital2022-08-0110079282core:SharePremium2022-08-0110079282core:RevaluationReserve2022-08-0110079282core:OtherReservesSubtotal2022-08-0110079282core:RetainedEarningsAccumulatedLosses2022-08-0110079282core:AfterOneYear2023-08-012024-07-3110079282core:WithinOneYear2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:CostValuation2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3110079282core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3110079282core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3110079282core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3110079282core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3110079282core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3110079282core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3110079282core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3110079282core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3110079282core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3110079282core:Non-currentFinancialInstrumentscore:CostValuation2023-07-3110079282core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-3110079282core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-3110079282core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-3110079282core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-3110079282core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-3110079282core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-3110079282core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-3110079282core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-3110079282bus:Director12023-08-012024-07-3110079282bus:Director22023-08-012024-07-31

DR JOHNSON DEVELOPMENTS LTD

Registered Number
10079282
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2024

DR JOHNSON DEVELOPMENTS LTD
Company Information
for the year from 1 August 2023 to 31 July 2024

Directors

ELITOK, Mehmet
ELITOK, Osman

Registered Address

205-207 Leabridge Road
Leyton
E10 7PN

Registered Number

10079282 (England and Wales)
DR JOHNSON DEVELOPMENTS LTD
Balance Sheet as at
31 July 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3,945,7313,309,673
3,945,7313,309,673
Current assets
Debtors139,000-
Cash at bank and on hand42,15783,399
181,15783,399
Creditors amounts falling due within one year3(3,230,767)(2,475,002)
Net current assets (liabilities)(3,049,610)(2,391,603)
Total assets less current liabilities896,121918,070
Creditors amounts falling due after one year4(843,497)(888,165)
Net assets52,62429,905
Capital and reserves
Called up share capital100100
Profit and loss account52,52429,805
Shareholders' funds52,62429,905
The financial statements were approved and authorised for issue by the Board of Directors on 30 January 2025, and are signed on its behalf by:
ELITOK, Mehmet
Director
ELITOK, Osman
Director

Registered Company No. 10079282
DR JOHNSON DEVELOPMENTS LTD
Notes to the Financial Statements
for the year ended 31 July 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20242023
Average number of employees during the year11
3.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables259,451729,130
Bank borrowings and overdrafts211,992119,712
Amounts owed to related parties2,746,7531,616,939
Taxation and social security12,5719,221
Total3,230,7672,475,002
4.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts843,497888,165
Total843,497888,165